FDA

The FDA is finally advising the food industry to stop using the euphemism "evaporated cane juice" for sugar on food labels. Ingredients on food labels should be couched in terms that the average person is familiar with. It's just too bad the advisory isn't binding.
A scathing report by the General Accountability Office, a federal watchdog organization, exposes serious flaws in the needed data collection by the FDA for fast-tracked drugs.
The FDA has greatly relaxed a previous lifetime ban on blood donations from gay men who have sex with men. But even this new policy is perceived by some as needlessly precautionary.
A new report finds that few entities administering clinical trials governmental agencies, nonprofits and academic institutions and private companies are reporting data to the government, as is required. The most common reason given for failure to do so on time (or at all) was that it's too much work.
The FDA has proposed a ban on indoor tanning for those under the age of 18. The potential measure adds further support to the already well-known hazards of indoor tanning, with melanoma, the deadliest form of skin cancers, being the most concerning.
At long last, the FDA approved biotech salmon, AquaAdvantage, which is bred to grow to twice the size of other fish. But in contrast to every scientific study and advisory, the editorial board of The New York Times writes that the genetically-modified fish should be labelled. We take issue with that position.
In 2012 the Center for Food Safety filed a petition with the FDA asking that the agency require that foods produced from genetically engineered (GMO) crops be labelled as such. Finally, the FDA has responded. It said "no."
The American Council was invited to the White House on the day of the 2015 Great American Smokeout to discuss regulating cigarette-smoking cessation and harm-reduction tools that are available to smokers looking to kick their deadly habit. We made several recommendations in the public's interest.
In a recent Wall St. Journal Op-Ed, former FDA associate commissioner Dr. Scott Gottlieb explains how the several-year-duration shortages of common generic drugs came about. That would be through excessive regulation, and not because of Big Pharma greed, which Hillary Clinton wants you to believe.
The FDA and CDC are expressing concerns about the potential for rising rates of transfusion-associated infections, with both agencies calling for more testing and precautions. Cash-strapped blood banks are not nearly so concerned.
Another expose of the phony dietary supplement industry scam by Dr. Pieter Cohen reminds us to warn all consumers about the dangers these useless and potentially toxic products pose to the unwary. Thanks to Dr. Cohen's work to keep this travesty in the news.
A new study links long-term, continuous use of common painrelievers (NSAIDs and aspirin) to a reduced risk of colorectal cancer (CRC). This study does not prove a cause-and-effect benefit, and these drugs can cause bleeding, so discuss with your doctor.